Mechanism of Protein Quality Control in Endoplasmic Reticulum of Animal Cell

动物细胞内质网蛋白质量控制机制

基本信息

  • 批准号:
    10660123
  • 负责人:
  • 金额:
    $ 1.98万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1998
  • 资助国家:
    日本
  • 起止时间:
    1998 至 1999
  • 项目状态:
    已结题

项目摘要

This project was planned to determine the relationship between structures and functions of ER-60 protease (ER-60) which was isolated from the endoplasmic reticulum (ER) of rat liver and characterized by the head investigator.Between 1998-1999, the experiments described below were carried out.1. ER-60 contains seven cysteine residues, four of which constitute two CGHC motifs which were assumed to include an active center cysteine residue (s) of the proteases. From the experiment with the recombinant human ER-60 with site-directed mutations of the C-terminal cysteine residues (Cys-60 and Cys-409) of the CGHC motifs to alanine, these cysteine residues were suggested to be an active center cysteine residue(s). The double-mutated enzyme with Cys-60 and Cys-409 both modified to alanine (C60A/C409A) showed no activity. The single-mutated enzymes, C60A and C409A exhibited activity. These results suggest the C-terminal cysteine residues of the CGHC motifs are responsible for the protease activity.2. ER-60 has been demonstrated to associate with substrate proteins (lysozyme or ApoB-100) or molecular chaperones (BiP and protein disulfide isomerase) in the ER lumen. The interaction of the recombinant human ER-60 and lysozyme or luminal molecular chaperones was analyzed with a surface plasmon resonance apparatus, BIAcore 2000. A specific, but not strong, interaction was observed between ER-60 and lysozyme, BiP, protein disulfide isomerase or calreticulin. Their kinetic parameters of the association and dissociation were different from each other. It was demonstrated that binding properties of BiP with unfolded polypeptide or ER-60 were different.3. The truncated ER-60 (K417 ochre), which was misfolded in the ER, was expressed in the COS-1 cell and determined the its fate after de novo synthesis. The overexposed K417 ochre was accumulated as insoluble aggregates. The stably expressed K417 ochre was degraded by a protease (s) inhibited by ALLN in the ER.
本项目主要研究从大鼠肝脏内质网(ER)中分离并鉴定的ER-60蛋白酶(ER-60)的结构与功能之间的关系。在1998-1999年间,进行了以下实验。ER-60含有7个半胱氨酸残基,其中4个构成了两个CGHC基序,这些基序被认为包含蛋白酶的活性中心半胱氨酸残基。通过CGHC基序c端半胱氨酸残基(Cys-60和Cys-409)突变为丙氨酸的重组人ER-60实验,这些半胱氨酸残基可能是一个活性中心半胱氨酸残基(s)。C60A/C409A修饰为丙氨酸的Cys-60和Cys-409双突变酶无活性。单突变酶C60A和C409A表现出活性。这些结果表明CGHC基序的c端半胱氨酸残基与蛋白酶活性有关。ER-60已被证明与内质网腔内的底物蛋白(溶菌酶或ApoB-100)或分子伴侣蛋白(BiP和蛋白二硫异构酶)结合。用BIAcore 2000表面等离子体共振仪分析重组人ER-60与溶菌酶或腔内分子伴侣的相互作用。ER-60与溶菌酶、BiP、蛋白二硫异构酶或钙网蛋白之间存在特异性但不强的相互作用。它们的缔合和解离动力学参数不同。结果表明,BiP与未折叠多肽或ER-60的结合特性不同。在ER中被错误折叠的ER-60 (K417 ochre)被截断后在COS-1细胞中表达,并决定了COS-1细胞重新合成后的命运。过度曝光的K417赭石以不溶性聚集体形式积累。稳定表达的K417 ochre在内质网中被一种被ALLN抑制的蛋白酶降解。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
H,Okudo, R.Urade, T.Moriyama and M.Kito: "Catalytic Cysteine Residues of ER-60 Protease"REBS Lett.. 465. 145-147 (2000)
H,Okudo,R.Urade,T.Moriyama 和 M.Kito:“ER-60 蛋白酶的催化半胱氨酸残基”REBS Lett.. 465. 145-147 (2000)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
R.Urade, M.Kusunose, T.Moriyama, T.Higasa and M.Kito]: "Accumulation and Degradation in the Endoplasmic Reticulum of a Truncated ER-60 Devoid of C-Terminal Amino Acid Rsidues"J.Biochem.. 127・3. 211-220 (2000)
R.Urade、M.Kusunose、T.Moriyama、T.Higasa 和 M.Kito]:“不含 C 末端氨基酸残基的截短 ER-60 在内质网中的积累和降解”J.Biochem.. 127・3.211-220(2000)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
R.Urade, A.Yasunishi, H.Okudo, M.Moriyama and M.Kito: "Autodegradation of Protein Disulfide Isomerase"Biosci.Biotechnol.Biochem.. 63. 610-613 (1999)
R.Urade、A.Yasunishi、H.Okudo、M.Moriyama 和 M.Kito:“蛋白质二硫键异构酶的自降解”Biosci.Biotechnol.Biochem.. 63. 610-613 (1999)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
R. Urade, A. Yasunishi, H. Okudo, M. Moriyama and M. Kito: "Autodegradation of Protein Disulfide Isomerase"Biosci. Biotechnol. Biochem.. 63. 610-613 (1999)
R. Urade、A. Yasunishi、H. Okudo、M. Moriyama 和 M. Kito:“蛋白质二硫键异构酶的自降解”Biosci。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
R..Urade, A.Yasunishi, H.Okudo, M.Moriyama and M.Kito: "Autodegradation of Protein Disulfide Isomerase"Biosici.Biotechnol.Biochem.. 63・3. 610-613 (1999)
R..Urade、A.Yasunishi、H.Okudo、M.Moriyama 和 M.Kito:“蛋白质二硫键异构酶的自降解”Biosici.Biotechnol.Biochem.. 63・3 (1999)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

URADE Reiko其他文献

URADE Reiko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('URADE Reiko', 18)}}的其他基金

Studies on physiological roles of ER-60 by tissue-specific gene targeting analysis
通过组织特异性基因靶向分析研究 ER-60 的生理作用
  • 批准号:
    21380081
  • 财政年份:
    2009
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Gene targeting analysis of the endoplasmic reticulum foldase ER-60
内质网折叠酶 ER-60 的基因打靶分析
  • 批准号:
    18380079
  • 财政年份:
    2006
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Studies on Regulatory Mechanism of Secretion of VLDL
VLDL分泌调控机制的研究
  • 批准号:
    13660124
  • 财政年份:
    2001
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Studies on Quality Control Mechanism of Proteins in Endoplasmic Reticulum
内质网蛋白质量控制机制研究
  • 批准号:
    08660155
  • 财政年份:
    1996
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Novel cysteine proteases involved in protein metabolism in endoplasmic reticulum of rat liver
参与大鼠肝脏内质网蛋白质代谢的新型半胱氨酸蛋白酶
  • 批准号:
    05660139
  • 财政年份:
    1993
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Investigating Autophagy-related Cysteine Protease Atg4a in Drosophila melanogaster Models of Cancer
研究果蝇癌症模型中与自噬相关的半胱氨酸蛋白酶 Atg4a
  • 批准号:
    495180
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
PLURIPOTENCY OF NOVEL TICK CYSTEINE PROTEASE INHIBITORS DURING HEMATOPHAGY
新型蜱半胱氨酸蛋白酶抑制剂在吸血过程中的多能性
  • 批准号:
    10515240
  • 财政年份:
    2022
  • 资助金额:
    $ 1.98万
  • 项目类别:
Hit to Lead Optimization of Non-Peptidic Inhibitors of Alphaviral Cysteine Protease
甲病毒半胱氨酸蛋白酶非肽抑制剂的优化
  • 批准号:
    10682095
  • 财政年份:
    2021
  • 资助金额:
    $ 1.98万
  • 项目类别:
Hit to Lead Optimization of Non-Peptidic Inhibitors of Alphaviral Cysteine Protease
甲病毒半胱氨酸蛋白酶非肽抑制剂的优化
  • 批准号:
    10196140
  • 财政年份:
    2021
  • 资助金额:
    $ 1.98万
  • 项目类别:
COVID-19 Variant Supplement - Optimizing polar, small inhibitors of a viral cysteine protease to identify a lead for an oral COVID-19 treatment
COVID-19 变异补充剂 - 优化病毒半胱氨酸蛋白酶的极性小抑制剂,以确定口服 COVID-19 治疗的先导药物
  • 批准号:
    443207
  • 财政年份:
    2021
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Operating Grants
COVID-19 Variant Network - Optimizing polar, small inhibitors of a viral cysteine protease to identify a lead for an oral COVID-19 treatment
COVID-19 变体网络 - 优化病毒半胱氨酸蛋白酶的极性小抑制剂,以确定口服 COVID-19 治疗的先导药物
  • 批准号:
    443337
  • 财政年份:
    2021
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Operating Grants
Optimizing polar, small inhibitors of a viral cysteine protease to identify a lead for an oral COVID-19 treatment
优化病毒半胱氨酸蛋白酶的极性小抑制剂以确定口服 COVID-19 治疗的先导药物
  • 批准号:
    429698
  • 财政年份:
    2020
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Operating Grants
Role of a schistosome cysteine protease in Th response polarization
血吸虫半胱氨酸蛋白酶在 Th 响应极化中的作用
  • 批准号:
    8444920
  • 财政年份:
    2013
  • 资助金额:
    $ 1.98万
  • 项目类别:
Role of splice- and translation-variants of the cysteine protease cathepsin L in the progression and metastasis of mammary cancer
半胱氨酸蛋白酶组织蛋白酶 L 的剪接和翻译变体在乳腺癌进展和转移中的作用
  • 批准号:
    233628567
  • 财政年份:
    2013
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Research Grants
Role of a schistosome cysteine protease in Th response polarization
血吸虫半胱氨酸蛋白酶在 Th 响应极化中的作用
  • 批准号:
    8721840
  • 财政年份:
    2013
  • 资助金额:
    $ 1.98万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了